Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
Sponsor: Covenant Health, US
Summary
The goal of this clinical trial is to determine if utilizing the Quest AD-Detect blood test, while patient's are hospitalized for a cognitive diagnosis (such as delirium or encephalopathy), will result in an earlier diagnosis of underlying Alzheimer's disease. * Will this blood test have the ability to distinguish between Alzheimer's disease and other causes of cognitive impairment in the inpatient setting? * Neurology Clinic will complete a 6-month post-hospitalization follow up with patients who have had the Quest AD-Detect Alzheimer's Disease blood test completed while they were inpatient to discuss the risk assessment portfolio
Key Details
Gender
All
Age Range
60 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-06-10
Completion Date
2026-03-31
Last Updated
2025-10-29
Healthy Volunteers
No
Conditions
Interventions
Quest AD-Detect blood test
Blood will be collected and sent for testing using the Quest AD-Detect blood test
Locations (6)
Cumberland Medical Center
Crossville, Tennessee, United States
Roane Medical Center
Harriman, Tennessee, United States
Fort Sanders Regional Medical Center
Knoxville, Tennessee, United States
Fort Loudon Medical Center
Lenoir City, Tennessee, United States
Methodist Medical Center
Oak Ridge, Tennessee, United States
LeConte Medical Center
Sevierville, Tennessee, United States